{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:56:37Z","timestamp":1791233797681,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s11060-025-05113-x","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T06:14:33Z","timestamp":1750659273000},"page":"165-174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cesium-131 collagen tile brachytherapy for salvage of recurrent intracranial metastases"],"prefix":"10.1007","volume":"175","author":[{"given":"Thomas H.","family":"Beckham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine E.","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Rooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.","family":"Tom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subha","family":"Perni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Frances","family":"McAleer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajat J.","family":"Kudchadker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surendra","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana","family":"Zlateva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chibawanye I.","family":"Ene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherise D.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason T.","family":"Huse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujit S.","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"5113_CR1","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1002\/cncr.25707","volume":"117","author":"C Nieder","year":"2011","unstructured":"Nieder C, Spanne O, Mehta MP, Grosu AL, Geinitz H (2011) Presentation, patterns of care, and survival in patients with brain metastases: what has changed in the last 20 years? Cancer 117:2505\u20132512. https:\/\/doi.org\/10.1002\/cncr.25707","journal-title":"Cancer"},{"key":"5113_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.adro.2019.07.012","volume":"5","author":"AB Barbour","year":"2020","unstructured":"Barbour AB et al (2020) Radiation therapy practice patterns for brain metastases in the united States in the stereotactic radiosurgery era. Adv Radiat Oncol 5:43\u201352. https:\/\/doi.org\/10.1016\/j.adro.2019.07.012","journal-title":"Adv Radiat Oncol"},{"key":"5113_CR3","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1038\/s41467-024-47998-8","volume":"15","author":"CI Ene","year":"2024","unstructured":"Ene CI et al (2024) Response of treatment-naive brain metastases to stereotactic radiosurgery. Nat Commun 15:3728. https:\/\/doi.org\/10.1038\/s41467-024-47998-8","journal-title":"Nat Commun"},{"key":"5113_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11060-021-03872-x","volume":"155","author":"JA Wilcox","year":"2021","unstructured":"Wilcox JA et al (2021) Salvage resection of recurrent previously irradiated brain metastases: tumor control and radiation necrosis dependency on adjuvant re-irradiation. J Neurooncol 155:277\u2013286. https:\/\/doi.org\/10.1007\/s11060-021-03872-x","journal-title":"J Neurooncol"},{"key":"5113_CR5","doi-asserted-by":"publisher","first-page":"e499","DOI":"10.1016\/j.prro.2023.05.010","volume":"13","author":"SM Buszek","year":"2023","unstructured":"Buszek SM et al (2023) Postoperative management of recurrence after radiosurgery and surgical resection for brain metastases and predicting benefit from adjuvant radiation. Pract Radiat Oncol 13:e499\u2013e503. https:\/\/doi.org\/10.1016\/j.prro.2023.05.010","journal-title":"Pract Radiat Oncol"},{"key":"5113_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3389\/fonc.2015.00084","volume":"5","author":"DE Holt","year":"2015","unstructured":"Holt DE et al (2015) Tumor bed radiosurgery following resection and prior stereotactic radiosurgery for locally persistent brain metastasis. Front Oncol 5:84. https:\/\/doi.org\/10.3389\/fonc.2015.00084","journal-title":"Front Oncol"},{"key":"5113_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11060-023-04407-2","volume":"164","author":"R De Pietro","year":"2023","unstructured":"De Pietro R et al (2023) The evolving role of reirradiation in the management of recurrent brain tumors. J Neurooncol 164:271\u2013286. https:\/\/doi.org\/10.1007\/s11060-023-04407-2","journal-title":"J Neurooncol"},{"key":"5113_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.wneu.2019.01.182","volume":"125","author":"S Chidambaram","year":"2019","unstructured":"Chidambaram S, Pannullo SC, Schwartz TH, Wernicke AG (2019) Reirradiation of recurrent brain metastases: where do we stand?? World Neurosurg 125:156\u2013163. https:\/\/doi.org\/10.1016\/j.wneu.2019.01.182","journal-title":"World Neurosurg"},{"key":"5113_CR9","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3171\/JNS\/2008\/108\/2\/0236","volume":"108","author":"BJ Darakchiev","year":"2008","unstructured":"Darakchiev BJ, Albright RE, Breneman JC, Warnick RE (2008) Safety and efficacy of permanent iodine-125 seed implants and carmustine wafers in patients with recurrent glioblastoma multiforme. J Neurosurg 108:236\u2013242. https:\/\/doi.org\/10.3171\/JNS\/2008\/108\/2\/0236","journal-title":"J Neurosurg"},{"key":"5113_CR10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1227\/00006123-200208000-00009","volume":"51","author":"RG Selker","year":"2002","unstructured":"Selker RG et al (2002) The brain tumor cooperative group NIH trial 87\u2013\u200901: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine. Neurosurgery 51:343\u2013355 discussion 355\u2013\u2009347","journal-title":"Neurosurgery"},{"key":"5113_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11060-023-04523-z","volume":"166","author":"MA Garcia","year":"2024","unstructured":"Garcia MA, Turner A, Brachman DG (2024) The role of gammatile in the treatment of brain tumors: a technical and clinical overview. J Neurooncol 166:203\u2013212. https:\/\/doi.org\/10.1007\/s11060-023-04523-z","journal-title":"J Neurooncol"},{"key":"5113_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s11060-023-04352-0","volume":"163","author":"ED Bander","year":"2023","unstructured":"Bander ED et al (2023) Safety and efficacy of Cesium-131 brachytherapy for brain tumors. J Neurooncol 163:355\u2013365. https:\/\/doi.org\/10.1007\/s11060-023-04352-0","journal-title":"J Neurooncol"},{"key":"5113_CR13","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s11060-022-04101-9","volume":"159","author":"BS Imber","year":"2022","unstructured":"Imber BS et al (2022) Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases. J Neurooncol 159:609\u2013618. https:\/\/doi.org\/10.1007\/s11060-022-04101-9","journal-title":"J Neurooncol"},{"key":"5113_CR14","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.3171\/2016.3.JNS152836","volume":"126","author":"AG Wernicke","year":"2017","unstructured":"Wernicke AG et al (2017) Cesium-131 brachytherapy for recurrent brain metastases: durable salvage treatment for previously irradiated metastatic disease. J Neurosurg 126:1212\u20131219. https:\/\/doi.org\/10.3171\/2016.3.JNS152836","journal-title":"J Neurosurg"},{"key":"5113_CR15","doi-asserted-by":"publisher","unstructured":"Choi M, Zabramski JM (2020) re-irradiation using brachytherapy for recurrent intracranial tumors: a systematic review and meta-analysis of the literature. Cureus 12, e9666 https:\/\/doi.org\/10.7759\/cureus.9666","DOI":"10.7759\/cureus.9666"},{"key":"5113_CR16","doi-asserted-by":"publisher","first-page":"vdac039","DOI":"10.1093\/noajnl\/vdac039","volume":"4","author":"KC Wu","year":"2022","unstructured":"Wu KC et al (2022) Salvage brachytherapy for multiply recurrent metastatic brain tumors: A matched case analysis. Neurooncol Adv 4:vdac039. https:\/\/doi.org\/10.1093\/noajnl\/vdac039","journal-title":"Neurooncol Adv"},{"key":"5113_CR17","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.brachy.2023.08.002","volume":"22","author":"T Kutuk","year":"2023","unstructured":"Kutuk T et al (2023) Surgically targeted radiation therapy (STaRT) for recurrent brain metastases: initial clinical experience. Brachytherapy 22:872\u2013881. https:\/\/doi.org\/10.1016\/j.brachy.2023.08.002","journal-title":"Brachytherapy"},{"key":"5113_CR18","doi-asserted-by":"publisher","first-page":"e19777","DOI":"10.7759\/cureus.19777","volume":"13","author":"KT Warren","year":"2021","unstructured":"Warren KT et al (2021) Surgical outcomes of novel collagen tile cesium brachytherapy for recurrent intracranial tumors at a tertiary referral center. Cureus 13:e19777. https:\/\/doi.org\/10.7759\/cureus.19777","journal-title":"Cureus"},{"key":"5113_CR19","doi-asserted-by":"publisher","unstructured":"Nakaji P et al (2020) Resection and Surgically Targeted Radiation Therapy for the Treatment of Larger Recurrent or Newly Diagnosed Brain Metastasis: Results From a Prospective Trial. Cureus 12, e11570 https:\/\/doi.org\/10.7759\/cureus.11570","DOI":"10.7759\/cureus.11570"},{"key":"5113_CR20","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3171\/jns.1995.82.3.0406","volume":"82","author":"PK Narotam","year":"1995","unstructured":"Narotam PK, van Dellen JR, Bhoola K (1995) D. A clinicopathological study of collagen sponge as a dural graft in neurosurgery. J Neurosurg 82:406\u2013412. https:\/\/doi.org\/10.3171\/jns.1995.82.3.0406","journal-title":"J Neurosurg"},{"key":"5113_CR21","doi-asserted-by":"publisher","first-page":"e0195608","DOI":"10.1371\/journal.pone.0195608","volume":"13","author":"J Moreau","year":"2018","unstructured":"Moreau J et al (2018) Second course of stereotactic radiosurgery for locally recurrent brain metastases: safety and efficacy. PLoS ONE 13:e0195608. https:\/\/doi.org\/10.1371\/journal.pone.0195608","journal-title":"PLoS ONE"},{"key":"5113_CR22","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.wneu.2017.04.103","volume":"104","author":"P Koffer","year":"2017","unstructured":"Koffer P et al (2017) Repeat stereotactic radiosurgery for locally recurrent brain metastases. World Neurosurg 104:589\u2013593. https:\/\/doi.org\/10.1016\/j.wneu.2017.04.103","journal-title":"World Neurosurg"},{"key":"5113_CR23","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s11060-019-03323-8","volume":"145","author":"C Iorio-Morin","year":"2019","unstructured":"Iorio-Morin C et al (2019) Repeat stereotactic radiosurgery for the management of locally recurrent brain metastases. J Neurooncol 145:551\u2013559. https:\/\/doi.org\/10.1007\/s11060-019-03323-8","journal-title":"J Neurooncol"},{"key":"5113_CR24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3171\/2016.5.JNS153051","volume":"127","author":"WH McKay","year":"2017","unstructured":"McKay WH et al (2017) Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery. J Neurosurg 127:148\u2013156. https:\/\/doi.org\/10.3171\/2016.5.JNS153051","journal-title":"J Neurosurg"},{"key":"5113_CR25","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3171\/2022.12.JNS221490","volume":"139","author":"RA Morshed","year":"2023","unstructured":"Morshed RA et al (2023) Identification of risk factors associated with leptomeningeal disease after resection of brain metastases. J Neurosurg 139:402\u2013413. https:\/\/doi.org\/10.3171\/2022.12.JNS221490","journal-title":"J Neurosurg"},{"key":"5113_CR26","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1093\/neuros\/nyy436","volume":"85","author":"RH Press","year":"2019","unstructured":"Press RH et al (2019) Hemorrhagic and cystic brain metastases are associated with an increased risk of leptomeningeal dissemination after surgical resection and adjuvant stereotactic radiosurgery. Neurosurgery 85:632\u2013641. https:\/\/doi.org\/10.1093\/neuros\/nyy436","journal-title":"Neurosurgery"},{"key":"5113_CR27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/neuonc\/noz144","volume":"22","author":"TK Nguyen","year":"2020","unstructured":"Nguyen TK et al (2020) Predictors of leptomeningeal disease following hypofractionated stereotactic radiotherapy for intact and resected brain metastases. Neuro Oncol 22:84\u201393. https:\/\/doi.org\/10.1093\/neuonc\/noz144","journal-title":"Neuro Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05113-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05113-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05113-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T22:05:26Z","timestamp":1757196326000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05113-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["5113"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05113-x","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The University of Texas MD Anderson Cancer Center\u2019s institutional review board reviewed and approved this study. Patient consent was not required due to minimal risk determination by the institutional review board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"THB, JSW, and RJK have received travel support from GT Medical Technologies to attend the Gammatile Practitioner\u2019s Society Meeting. THB has received consulting fees from GT Medical Technologies (relationship not active). MCT has received meeting travel support from Brainlab, consulting fees from Viewray, and honoraria from Elsevier.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}